Galmed Pharmaceuticals
GLMD
#10438
Rank
โ‚ฌ3.9 M
Marketcap
0,71ย โ‚ฌ
Share price
-0.62%
Change (1 day)
-74.68%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2025 (TTM): -3,46ย โ‚ฌ

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,33ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -151,23ย โ‚ฌ an increase over its 2016 EPS that were of -229,93ย โ‚ฌ.

EPS history for Galmed Pharmaceuticals from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,46ย โ‚ฌ
2017-151,23ย โ‚ฌ-34.23%
2016-229,93ย โ‚ฌ56.84%
2015-146,60ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Catalent
CTLT
-5,43ย โ‚ฌ 62.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-0,92ย โ‚ฌ-72.49%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-0,64ย โ‚ฌ-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Evoke Pharma
EVOK
-2,16ย โ‚ฌ-35.22%๐Ÿ‡บ๐Ÿ‡ธ USA